Cargando…
Dynamic Stability of Volatile Organic Compounds in Respiratory Air in Schizophrenic Patients and Its Potential Predicting Efficacy of TAAR Agonists
Objectives: Volatile organic compounds (VOCs) in the breathing air were found to be altered in schizophrenia patients compared to healthy participants. The aim of this study was to confirm these findings and to examine for the first time whether these VOCs are stable or change in concentration durin...
Autores principales: | Held, Anna, Henning, Dariush, Jiang, Carina, Hoeschen, Christoph, Frodl, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254278/ https://www.ncbi.nlm.nih.gov/pubmed/37298866 http://dx.doi.org/10.3390/molecules28114385 |
Ejemplares similares
-
Gut–brain axis volatile organic compounds derived from breath distinguish between schizophrenia and major depressive disorder
por: Henning, Daniush, et al.
Publicado: (2023) -
Volatile Organic Compounds From Breath Differ Between Patients With Major Depression and Healthy Controls
por: Lueno, Marian, et al.
Publicado: (2022) -
Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia
por: Heffernan, Michele L. R., et al.
Publicado: (2021) -
Structural and Functional Evolution of the Trace Amine-Associated Receptors TAAR3, TAAR4 and TAAR5 in Primates
por: Stäubert, Claudia, et al.
Publicado: (2010) -
Biological evaluation and in silico studies of novel compounds as potent TAAR1 agonists that could be used in schizophrenia treatment
por: Wang, Yunjie, et al.
Publicado: (2023)